Article

wsj.com on 2021-08-02 11:04

Eli Lilly’s New Compliance Chief on His Priorities6 min read

Technological innovation, the coronavirus pandemic and a shifting regulatory landscape are top of mind for Eli Lilly’s new compliance chief, Alonzo Weems.

Canada

Related news

Eli Lilly’s New Compliance Chief on His Priorities6 min read wsj.com
Canada
BEli Lilly’s Growth Is Set to Soar Under CEO David Ricks1 min read barrons.com
Denmark
Credit Suisse Names New Chief Compliance Officer2 min read wsj.com
Wall Street , Switzerland , Canton of Zurich
Rio Tinto Taps Former Unilever Compliance Officer for Top Legal Post2 min read wsj.com
Guinea , Israel , Australia , Europe , Canada
Binance Bolsters Its Compliance Team as Scrutiny of Crypto Increases2 min read wsj.com
Canada , Europe , China , Japan
Federal Court finds Eli Lilly’s tadalafil dosage form and process patents invalid jdsupra.com
Canada
BLilly’s Growth Is Set to Soar Under CEO Ricks1 min read barrons.com
Denmark
Eli Lilly’s Profit Dented by Higher Costs wsj.com
FDA Approves Eli Lilly’s Alzheimer’s Drug Donanemab Forbes
MEli Lilly hikes quarterly dividend 15%1 min read marketwatch.com
Eli Lilly’s Compliance Head on ‘Capturing Hearts’blogs.wsj.com
Neiman Marcus Appoints New Compliance Chief1 min read wsj.com
Americas , King of Prussia
Marsh & McLennan Appoints Dedicated Compliance Chief1 min read wsj.com
Tribunal dismisses Eli Lilly’s NAFTA challenge on promise utility doctrine jdsupra.com
Canada , Free Trade
Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern The New York Times
Veterans Affairs
MEli Lilly’s therapy with solanezumab didn’t decelerate the illness mvtelegraph.com
Brigham City
Eli Lilly’s EFFIENT combination use patent found obvious jdsupra.com
California , United States , Switzerland
Eli Lilly’s sees strength in 2017, shares take off seattletimes.com
FHigh stakes: Eli Lilly’s hunt for an Alzheimer’s drug ft.com
South East Asia , China